SG72632A1 - Treatment of non-ulcer dyspepsia with bismuth salts - Google Patents

Treatment of non-ulcer dyspepsia with bismuth salts

Info

Publication number
SG72632A1
SG72632A1 SG1996004300A SG1996004300A SG72632A1 SG 72632 A1 SG72632 A1 SG 72632A1 SG 1996004300 A SG1996004300 A SG 1996004300A SG 1996004300 A SG1996004300 A SG 1996004300A SG 72632 A1 SG72632 A1 SG 72632A1
Authority
SG
Singapore
Prior art keywords
treatment
bismuth salts
ulcer dyspepsia
dyspepsia
ulcer
Prior art date
Application number
SG1996004300A
Inventor
Thomas Julius Borody
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3771057&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG72632(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of SG72632A1 publication Critical patent/SG72632A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG1996004300A 1985-04-18 1986-04-18 Treatment of non-ulcer dyspepsia with bismuth salts SG72632A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPH019885 1985-04-18

Publications (1)

Publication Number Publication Date
SG72632A1 true SG72632A1 (en) 2000-05-23

Family

ID=3771057

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996004300A SG72632A1 (en) 1985-04-18 1986-04-18 Treatment of non-ulcer dyspepsia with bismuth salts

Country Status (5)

Country Link
EP (1) EP0222834A4 (en)
JP (1) JPS62502967A (en)
AU (1) AU590578B2 (en)
SG (1) SG72632A1 (en)
WO (1) WO1986005981A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE135582T1 (en) * 1985-06-13 1996-04-15 Barry James Marshall METHODS AND COMPOSITIONS FOR TREATING GASTROINTESTINAL DISORDERS
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
ATE81011T1 (en) * 1987-03-09 1992-10-15 Procter & Gamble COMPOSITIONS AND THEIR USE IN THE TREATMENT OF GASTROINTESTINAL DISORDERS.
JP2733849B2 (en) * 1987-10-12 1998-03-30 ボロディー，ソーマス・ユリウス Improved method for treating gastrointestinal disorders
AU623868B2 (en) * 1987-10-12 1992-05-28 Capability Services Pty. Limited Improved method for treatment of gastrointestinal disorders
US4935406A (en) * 1988-09-20 1990-06-19 Marion Laboratories, Inc. Use of bismuth (phosph/sulf)ated saccharides against Camplyobacter-associated gastrointestinal disorders
EP0375068A1 (en) * 1988-12-23 1990-06-27 Gist-Brocades N.V. Combining bismuth compounds and tetracyclines
EP0403048A3 (en) * 1989-06-14 1991-01-30 Warner-Lambert Company Medicated compositions containing sucralfate and processes for their production
FI910088A (en) * 1990-01-09 1991-07-10 Gist Brocades Nv ORAL PHARMACEUTICAL COMPOSITION.
YU45590A (en) * 1990-03-07 1992-07-20 PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. NEW COMPLEXES OR CHELATES OF ANTIBIOTICS WITH TWO-VALENT AND / OR TROVALENT METALS AND PROCEDURES FOR THEIR OBTAINING
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
DE59309771D1 (en) * 1993-05-11 1999-10-14 Spirig Ag Solid bismuth and amoxycillin medicinal product and its use
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
PE48297A1 (en) * 1995-05-09 1998-02-04 Procter & Gamble METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISORDERS
US5744168A (en) * 1995-12-07 1998-04-28 The Procter & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US6051604A (en) * 1995-12-07 2000-04-18 The Proctor & Gamble Company Methods and compositions for the prevention and treatment of gastrointestinal disorders
US5702729A (en) * 1995-12-07 1997-12-30 The Procter & Gamble Company Methods for the prevention and treatment of gastrointestinal disorders caused or mediated by algae or cyanobacteria
AUPS088702A0 (en) 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
MX355760B (en) 2010-12-13 2018-04-27 Salix Pharmaceuticals Inc Gastric and colonic formulations and methods for making and using them.
DK2877163T3 (en) 2012-07-27 2019-04-15 Redhill Biopharma Ltd FORMULATIONS AND PROCEDURES FOR THE PREPARATION OF FORMS FOR USING GAS DRAINAGE

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6063965A (en) * 1965-06-25 1967-01-05 Morton W. Scott Belayed acting compositions
US3621094A (en) * 1968-04-05 1971-11-16 Smith Kline French Lab Concentrated aqueous liquid antacid compositions containing certain phosphate and gluconate salts
GB1269987A (en) * 1968-04-18 1972-04-12 Garland Richard Brown Antacid composition
GB1220819A (en) * 1968-04-24 1971-01-27 Mar Pha Soc D Etude Et D Expl Improved bismuth salt
US4153685A (en) * 1968-11-23 1979-05-08 Schering Corporation Bismuth complex preparations
FR2029402A1 (en) * 1969-01-28 1970-10-23 Breive Et Son Jib Labo Regulation of digestion in gastro intestinal - passage
FR2053002A1 (en) * 1969-06-21 1971-04-16 Clin Midy Bismuth slats of alpha methiminobenzyl - penicillin
FR2073254A2 (en) * 1969-12-04 1971-10-01 Dausse Laboratoire Gum guar stabilised suspensions - of insoluble medicaments for treati gastrointestinal disorders
AU440535B2 (en) * 1969-12-18 1973-09-17 Export Drugs Company Antacid compositions
FR2092636A1 (en) * 1970-06-03 1972-01-28 Griffon Henri Dried yeast - bismuth subnitrate compositions - for gastrointestinal disorders
ZA74385B (en) * 1974-01-18 1975-08-27 Gist Brocades Nv Pharmaceutical compositions
HU179474B (en) * 1978-02-24 1982-10-28 Laszlo Gyarmati Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material
PH20649A (en) * 1981-09-22 1987-03-16 Gist Brocades Nv Bismuth containing composition and method for the preparation thereof
US4588589A (en) * 1983-10-13 1986-05-13 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
ATE135582T1 (en) * 1985-06-13 1996-04-15 Barry James Marshall METHODS AND COMPOSITIONS FOR TREATING GASTROINTESTINAL DISORDERS
EP0206627B1 (en) * 1985-06-13 1992-08-12 Barry James Dr. Marshall Methods for the treatment of gastrointestinal disorders

Also Published As

Publication number Publication date
EP0222834A4 (en) 1989-10-04
AU590578B2 (en) 1989-11-09
EP0222834A1 (en) 1987-05-27
JPS62502967A (en) 1987-11-26
WO1986005981A1 (en) 1986-10-23
AU5902686A (en) 1986-11-05

Similar Documents

Publication Publication Date Title
SG72632A1 (en) Treatment of non-ulcer dyspepsia with bismuth salts
GB8607827D0 (en) Submerged combustion calcination
ZA86246B (en) Ribbon cassettes
HUT35513A (en) Solutions of lactates of piperazinyl-quinoline-quinoline- and piperazinyl-azaquinolone-carboxylic acids
GB8618255D0 (en) Preservation of plants
GB2182192A8 (en) Timer for recorders
ZA852042B (en) Crystalline ceftazidime salts
GB2189239B (en) Furosemide salts
GB8526924D0 (en) Bisimidazolium salts
PT82950A (en) Process for the preparation of antimicrobian isothiazolone solutions
DK34585D0 (en) ANTIBACTERIAL NAPHTHYRIDINE AND PYRIDOPYRIMIDINE COMPOUNDS
ZW21486A1 (en) Salts of benzoylureas
GR861673B (en) Active chemical compounds preparation method
GB8606207D0 (en) Polyacrylamide solutions
GB8514080D0 (en) Imidazopyridine compounds
GB8601643D0 (en) Ribbon cassettes
GB8616072D0 (en) Treatment of continuous ribbons
GB8505065D0 (en) Sterilising solutions
IE850743L (en) Ceftazidime salts
ZA868191B (en) Salts of benzoylureas
ZA85403B (en) Naphthyridine and pyridopyrimidine antibacterial compounds
GB8516549D0 (en) Complex salts
IE852940L (en) Salts of 1-phenylimidazole -5-carboxylic acids
PL256108A1 (en) Method of obtaining substituted 2-furanyl- or 5-oxo-2-furanyl-alkoxy-phosphoryl-alkylo-cyclimonic salts
IE850882L (en) Phenoxypropanolamine salts